#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypergammaglobulinaemia benign monoclonal Infertility female Clear cell papillary renal cell carcinoma Acute respiratory distress syndrome Epstein-Barr virus associated lymphoproliferative disorder Activated PI3 kinase delta syndrome Warm autoimmune haemolytic anaemia Infertility male Blastic plasmacytoid dendritic cell neoplasia Hyperoxaluria Primary hyperoxaluria Glycogen storage disease type I Carcinoid tumour Cortical dysplasia Colon cancer More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Trials in Disease Familial amyotrophic lateral sclerosis – Diagnostics Mantle cell lymphoma stage III – Trials in Disease Optic glioma – Life with Disease Haemolytic uraemic syndrome – Trials in Disease Splenic marginal zone lymphoma – Trials in Disease Myelodysplastic syndrome with excess blasts – Life with Disease Mucous membrane pemphigoid Glomerulonephritis rapidly progressive – Diagnostics Nephrotic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Capsaicin Vosoritide Ethambutol Hydrochloride Caffeine Citrate Bms-986315 For-6219 Ambrosia Artemisiifolia (302) HTL0022537 [68GA]GA-NOTA-AE105 Darolutamide Acetylcysteine Cenobamate Ioflupane (123I) Betula Pollen Extract Migalastat Fremanezumab Icosapent Ethyl Tezepelumab LY3537021 Adrc001 More therapies…

    Learn about Your Condition

    Epstein-Barr virus infection Reperfusion injury Arteriovenous malformation Bile acid synthesis disorder Insulin resistance Systemic sclerosis pulmonary Renal cancer Primary myelofibrosis Medulloblastoma Acne Meningioma Colorectal adenoma Post procedural swelling Osteonecrosis of jaw Cardiogenic shock More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Tolna Vármegyei Balassa János Kórház

Tolna Vármegyei Balassa János Kórház

Beri Balogh Adam Utca 5-7, Szekszard, 7100, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Abemaciclib
    • Leuprorelin Acetate
    • Palbociclib
    Austria Belgium Bulgaria France Germany Hungary +6

  • Study on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab Emtansine
    • Trastuzumab
    Germany Hungary Italy Spain

  • Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Hungary Italy +5

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Czechia France Germany Hungary +5

  • Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Docetaxel
    • Durvalumab
    • Fluorouracil
    Belgium Denmark France Germany Hungary The Netherlands +2

  • Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capivasertib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +1

  • Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Capecitabine
    • Fluorouracil
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Bemarituzumab
    • Fluorouracil
    • Folinic Acid
    Belgium Bulgaria Czechia Denmark Estonia France +12

  • Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epirubicin
    • Olaparib
    • Capecitabine
    Austria Belgium Bulgaria France Germany Hungary +3

  • Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    • Palbociclib
    • Anastrozole
    Austria Belgium Bulgaria Czechia France Germany +7
Previous Page
1 2 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!